Solana Co (HSDT): Nasdaq/NYSE listing notice — Helius Medical gets Nasdaq delisting warning for equity <$2.5M; extension to June 30, 2025

Solana Co

Received Nasdaq notice on March 31, 2025 for stockholders' equity below $2.5M from FY2024 10-K.
Also failed minimum bid price requirement; hearing held March 18, 2025.
Company does not meet alternative compliance standards for continued listing.
Nasdaq granted extension to June 30, 2025 to regain compliance with both rules.
Stock continues trading on Nasdaq under HSDT with no immediate impact.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Solana Co received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

March 31, 2025, Helius Medical Technologies, Inc. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company no longer complies with the minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”) for continued listing on The Nasdaq Stock Market LLC because the Company’s stockholders’ equity, as reported in the Company’s Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2024, has fallen below $2.5 million. The notice also indicates that the Com

View on SEC.gov

Browse all listing & compliance notices →

Solana Co filing history →

Source: SEC EDGAR

accession 0001558370-25-004488

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.